Synopsis
Recognise acute phosphate-related respiratory and cellular dysfunction, prevent refeeding harm and manage renal phosphate excess without unsafe replacement.
- Phosphate is essential for ATP, 2,3-DPG, cell membranes, signalling and bone mineral, so severe deficiency can impair diaphragm, myocardium, brain, erythrocytes and leukocyte function.
- A rapid intracellular shift follows refeeding, insulin treatment, respiratory alkalosis and recovery from DKA, and can produce profound symptoms despite a smaller preceding extracellular abnormality.
- NICE identifies low phosphate, potassium or magnesium and prolonged minimal intake as major refeeding-risk features; prevention begins before calories are advanced.
- Reduced absorption, vitamin D deficiency, diarrhoea, antacids and phosphate binders cause deficiency, while PTH or FGF23 excess and Fanconi syndromes cause renal wasting.
- MHRA warns that repeated or high-dose ferric carboxymaltose can cause persistent hypophosphataemic osteomalacia and fractures, requiring risk-based phosphate monitoring and treatment review.
- Use oral phosphate for suitable stable deficiency and reserve intravenous replacement for severe symptoms or very low concentrations, following a product-specific local chart with calcium, potassium and renal monitoring.
- Hyperphosphataemia most commonly reflects acute or chronic kidney failure, tissue breakdown, tumour lysis, hypoparathyroidism or an exogenous phosphate load.
- Chronic CKD management integrates dialysis adequacy, specialist diet and phosphate binders taken with food; it is not solved by reacting to one result or restricting protein indiscriminately.
Key red flags
New difficulty weaning ventilation, shallow breathing, weak cough or reduced vital capacity can reflect severe phosphate depletion and warrants urgent confirmation and replacement.
Proximal weakness, rhabdomyolysis, haemolysis, impaired platelet function, confusion or seizure indicates systemic consequences beyond an incidental laboratory result.
Oedema, tachycardia, weakness, delirium or respiratory deterioration after nutrition starts in a malnourished patient should prompt immediate phosphate, magnesium and potassium review.
Tetany, paraesthesia, QT prolongation or seizure after cell lysis, bowel preparation or phosphate administration may result from secondary hypocalcaemia and renal failure.
Investigation priorities
Confirm direction and assess reciprocal calcium change and precipitation risk.
Management branches
An adult has prolonged minimal intake, major weight loss, alcohol dependence or low baseline phosphate, potassium or magnesium.
- Apply NICE CG32 refeeding-risk criteria before nutrition, obtain baseline electrolytes and glucose and prescribe thiamine and multivitamin support through the local nutrition protocol.
- Start energy at the guideline rate appropriate to risk and replace potassium, phosphate and magnesium through planned oral, enteral or intravenous routes rather than waiting for symptoms.
- Monitor fluid balance, oedema, heart rate, respiratory status and electrolytes daily or more frequently, slowing nutritional progression and escalating when biochemical or organ dysfunction emerges.